Body's anti-HIV drug explained
October 13, 2008
Nature study reveals long-sought atomic structure of key enzyme and suggests new approach for drug development
Humans have a built-in weapon against HIV, but until recently no one knew how to unlock its potential.
A study published online by the journal Nature reveals the atomic structure of this weapon - an enzyme known as APOBEC-3G - and suggests new directions for drug development.
APOBEC-3G is present in every human cell. It is capable of stopping HIV at the first step of replication, when the retrovirus transcribes its RNA into viral DNA.
The study's authors, led by Xiaojiang Chen of the University of Southern California, were able to show the atomic structure of the active portion of APOBEC-3G.
The discovery suggests how and where the enzyme binds to the viral DNA, mutating and destroying it.
"We understand how this enzyme can interact with DNA," said Chen, a professor of molecular and computational biology at USC. "This understanding provides a platform for designing anti-HIV drugs."
If APOBEC-3G works so well, why do people get AIDS? Because the HIV virus has evolved to encode the protein Vif, known as a "virulence factor," that blocks APOBEC-3G.
With APOBEC-3G out of the way, the RNA of the HIV virus can be successfully transcribed to viral DNA, an essential step for infection and for producing many more HIV viruses.
Chen said his group's research offers important clues on where Vif binds to APOBEC-3G. The knowledge could be used to design drugs that would prevent Vif from binding and allow APOBEC-3G to do its job, Chen said.
That would unlock humans' innate ability to fight HIV.
"We were born with it, and it's there waiting," Chen said.
In addition to fighting HIV, APOBEC-3G can inhibit the Hepatitis B virus. Other members of the APOBEC family serve important roles in antibody maturation, fat metabolism and heart development.
Mapping the structure of APOBEC-3G at the atomic level is a goal that "has been sought after worldwide because of its significance," Chen said.
University of Southern California
|
|
Two new anti-HIV drugs provide effective combo.(Infectious Diseases): An article from: Internal Medicine News
by Mitchel L. Zoler (Author)
This digital document is an article from Internal Medicine News, published by International Medical News Group on December 1, 2004. The length of the article is 572 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Two new anti-HIV drugs provide effective combo.(Infectious Diseases) Author: Mitchel L. Zoler Publication: Internal Medicine News (Magazine/Journal) Date: December 1, 2004 Publisher: International Medical News Group Volume: 37 Issue: 23 Page: 52(1)
Distributed by Thomson...
|
|
|
T-20, New Kind of Anti-HIV Drug, Looks Good.: An article from: Family Practice News
by Mitchel L. Zoler (Author)
This digital document is an article from Family Practice News, published by International Medical News Group on February 15, 2000. The length of the article is 2725 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: T-20, New Kind of Anti-HIV Drug, Looks Good. Author: Mitchel L. Zoler Publication: Family Practice News (Magazine/Journal) Date: February 15, 2000 Publisher: International Medical News Group Volume: 30 Issue: 4 Page: 67
Distributed by Thomson...
|
|
|
FDA APPROVES GILEAD'S ANTI-HIV DRUG VIREAD.: An article from: Biotech Business
by Worldwide Videotex (Publisher)
This digital document is an article from Biotech Business, published by Worldwide Videotex on December 1, 2001. The length of the article is 1206 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: FDA APPROVES GILEAD'S ANTI-HIV DRUG VIREAD. Publication: Biotech Business (Newsletter) Date: December 1, 2001 Publisher: Worldwide Videotex Volume: 14 Issue: 12 Page: NA
Distributed by Thomson Gale
|
|
|
Blood fat levels and anti-HIV drugs: now what?: An article from: HIV Treatment: ALERTS!
by Ben J. Barnett (Author), Mario Maldonado (Author)
This digital document is an article from HIV Treatment: ALERTS!, published by The Center for AIDS: Hope & Remembrance Project on July 1, 2001. The length of the article is 1960 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Blood fat levels and anti-HIV drugs: now what? Author: Ben J. Barnett Publication: HIV Treatment: ALERTS! (Newsletter) Date: July 1, 2001 Publisher: The Center for AIDS: Hope & Remembrance Project Page: 6(4)
Distributed by Thomson...
|
|
|
Two new anti-HIV drugs provide effective combo.(Infectious Diseases): An article from: Family Practice News
by Mitchel L. Zoler (Author)
This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2005. The length of the article is 575 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Two new anti-HIV drugs provide effective combo.(Infectious Diseases) Author: Mitchel L. Zoler Publication: Family Practice News (Magazine/Journal) Date: February 1, 2005 Publisher: International Medical News Group Volume: 35 Issue: 3 Page: 32(1)
Distributed by Thomson...
|
|
|
Start anti-HIV drugs earlier, new federal guidelines say.(INFECTIOUS DISEASES): An article from: Skin & Allergy News
by Unavailable (Author)
This digital document is an article from Skin & Allergy News, published by International Medical News Group on February 1, 2010. The length of the article is 516 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details Title: Start anti-HIV drugs earlier, new federal guidelines say.(INFECTIOUS DISEASES) Author: Unavailable Publication: Skin & Allergy News (Magazine/Journal) Date: February 1, 2010 Publisher: International Medical News Group Volume: 41 Issue: 2 Page: 16(1)
Distributed by Gale, a part of Cengage...
|
|
|
Start anti-HIV drugs earlier, new federal guidelines say.(INFECTIOUS DISEASES)(Clinical report): An article from: Internal Medicine News
by Sherry Boschert (Author)
This digital document is an article from Internal Medicine News, published by International Medical News Group on January 1, 2010. The length of the article is 637 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details Title: Start anti-HIV drugs earlier, new federal guidelines say.(INFECTIOUS DISEASES)(Clinical report) Author: Sherry Boschert Publication: Internal Medicine News (Magazine/Journal) Date: January 1, 2010 Publisher: International Medical News Group Volume: 43 Issue: 1 Page: 54(1)
Article Type: Clinical report
Distributed by Gale, a part of Cengage...
|
|
|
Anti-HIV Agents, Drugs and Substances: Index and Medical Analysis of New Research Information
by Abbe Research Division (Author)
|
|
|
Long-term drug holidays may help HIV patients: 20-month trial.(Infections Diseases): An article from: Internal Medicine News
by Bruce Jancin (Author)
This digital document is an article from Internal Medicine News, published by International Medical News Group on November 15, 2003. The length of the article is 619 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Long-term drug holidays may help HIV patients: 20-month trial.(Infections Diseases) Author: Bruce Jancin Publication: Internal Medicine News (Magazine/Journal) Date: November 15, 2003 Publisher: International Medical News Group Volume: 36 Issue: 22 Page: 23(1)
Distributed by Thomson...
|